Sinotherapeutics Inc. (SHA:688247)
China · Delayed Price · Currency is CNY 11.09
-0.09 (-0.81%)
At close: Sep 15, 2025
Sinotherapeutics Revenue
Sinotherapeutics had revenue of 110.68M CNY in the quarter ending June 30, 2025, with 3.84% growth. This brings the company's revenue in the last twelve months to 513.23M, up 26.07% year-over-year. In the year 2024, Sinotherapeutics had annual revenue of 511.62M with 70.61% growth.
Revenue (ttm)
513.23M
Revenue Growth
+26.07%
P/S Ratio
9.78
Revenue / Employee
1.64M
Employees
312
Market Cap
5.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 511.62M | 211.75M | 70.61% |
| Dec 31, 2023 | 299.87M | 52.31M | 21.13% |
| Dec 31, 2022 | 247.56M | -67.91M | -21.53% |
| Dec 31, 2021 | 315.47M | -3.69M | -1.16% |
| Dec 31, 2020 | 319.16M | 180.30M | 129.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |